Objective: Determination of frequency of BCR-ABL1 gene mutation in Acute 1Substantial contributions to the Lymphoblastic Leukemia. conception or design of the work; Methodology: This cross sectional study was carried out at the Department of or the acquisition, analysis, or Molecular Haematology, Armed Forces Institute of Pathology between January interpretation of data for the work 2018 to March 2021. All newly diagnosed patients of Acute Lymphoblastic 2bFeinpaulbalipsphreodval of the version to Leukemia were included in the study while patients already on treatment and 3,4 ,5Drafting the work or revising it with secondary leukemia were excluded from the study. Blood counts were critically for important intellectual done and various parameters such as total leukocyte count, hemoglobin, and content,6 Active participation in platelet count were calculated. active methodology Results: 623 patients were included in the study. BCR-ABL gene was positive in Funding Source: None 105 (16.8%) patients. A total of 96 (92%) were positive for BCR ABL p190 Conflict of Interest: None rearrangement and 9 (8%) were positive for BCR ABL p210 Received: Mar 01, 2022 rearrangement. Mean age of patients was 21 years. The frequency of BCR ABL Accepted: Aug 11, 2022 gene was positive in 72% males and 28% females. BCR-ABL positive ALL was Address of Correspondent associated with higher TLC count. CNS involvement was more common in Acute Dr. Mohammad Shabih Haider Lymphoblastic Leukemia with BCR-ABL. The likelihood of post-induction FCPS Trainee, Pathology remission decreased with age. (Haematology), Armed forces Conclusion: In our study population, a frequency of 16.8% patients were BCR Institute of Pathology Rawalpindi ABL1 positive in acute lymphoblastic leukemia. BCR- ABL gene mutation in ALL is shabihhaider007@hotmail.com more prevalent in young adults. The frequency of p190 rearrangement is more common than p210 BCR-ABL rearrangement. BCR-ABL positive ALL is more prevalent in males than in females.